文献速递垂体与肾上腺疾病

降压药洗脱前醛固酮与肾素比值在原发性醛固酮增多症筛查中的效能

Performance of Aldosterone-to-renin Ratio Before Washout of Antihypertensive Drugs in Screening of Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本回顾性分析纳入2017年1月至2022年5月在本机构筛查继发性高血压的连续患者1306例,评估降压药洗脱前醛固酮与肾素比值(ARR)筛查原发性醛固酮增多症(PA)的效能。确诊试验显示PA 215例(16.5%),原发性高血压1091例(83.5%)。洗脱前ARR界值0.7(ng/dL)/(μIU/mL)时敏感性96.3%、特异性61.2%、阳性预测值0.33、阴性预测值0.99。

要点

  • 洗脱前ARR界值0.7(ng/dL)/(μIU/mL)筛查PA的敏感性为96.3%,阴性预测值为0.99。
  • 洗脱前ARR≤0.7(ng/dL)/(μIU/mL)时,作者认为可省略洗脱且无需进一步检查PA。
  • 与第二次筛查相比,第一次筛查(洗脱前)在PA和EH组均显示血浆醛固酮更低、肾素更高,故ARR更低。

核心结论

  • 降压药洗脱前ARR是筛查PA的敏感试验。
  • 若洗脱前ARR≤0.7(ng/dL)/(μIU/mL),可省略降压药洗脱,且无需进一步检查PA。

研究设计与样本

  • 回顾性分析,纳入2017年1月至2022年5月在本机构筛查继发性高血压的连续患者。
  • 最终分析要求洗脱前和停用降压药后均有ARR可用。
  • 洗脱后ARR≥2.4(ng/dL)/(μIU/mL)的患者进入确诊试验,PA诊断基于确诊试验阳性结果。
  • 共纳入1306例患者,中位年龄50.2(41.0-59.0)岁,男性64.0%。

主要发现

  • 确诊试验显示PA 215例(16.5%),原发性高血压1091例(83.5%)。
  • 与第二次筛查相比,第一次筛查(洗脱前)在PA组和EH组均显示血浆醛固酮更低、肾素更高,故ARR更低。
  • 洗脱前ARR界值0.7(ng/dL)/(μIU/mL)时,敏感性96.3%、特异性61.2%、阳性预测值0.33、阴性预测值0.99。
  • 洗脱前ARR界值0.5(ng/dL)/(μIU/mL)时,敏感性97.7%、特异性52.0%、阳性预测值0.29、阴性预测值0.99。

关键数值与推荐

  • 洗脱后ARR≥2.4(ng/dL)/(μIU/mL)进入确诊试验。
  • 洗脱前ARR界值0.7(ng/dL)/(μIU/mL):敏感性96.3%、特异性61.2%、阳性预测值0.33、阴性预测值0.99。
  • 洗脱前ARR界值0.5(ng/dL)/(μIU/mL):敏感性97.7%、特异性52.0%、阳性预测值0.29、阴性预测值0.99。

临床怎么用

  • 作者认为洗脱前ARR是筛查PA的敏感试验。
  • 作者认为若洗脱前ARR≤0.7(ng/dL)/(μIU/mL),可省略降压药洗脱,且无需进一步检查PA。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to evaluate performance of aldosterone-to-renin ratio (ARR) before washout of antihypertensive drugs as a screening test for primary aldosteronism (PA). METHODS: This retrospective analysis included consecutive patients screening for secondary hypertension during a period from January 2017 to May 2022 at the authors' institute. For inclusion in the final analysis, ARR had to be available prior to as well as after discontinuation of antihypertensives. Patients with ARR ≥2.4(ng/dL)/(μIU/mL) after washout proceeded to confirmatory tests. Diagnosis of PA was established based on a positive result of the confirmatory test. The diagnostic accuracy of ARR prior to the washout in predicting PA is shown as sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). RESULTS: The analysis included a total of 1306 patients [median age of 50.2 (41.0-59.0) years, 64.0% male]. Confirmatory tests showed PA in 215(16.5%) patients and essential hypertension (EH) in the remaining 1091(83.5%) patients. In comparison to the second screening test, the first screening test (before washout of antihypertensives) yielded lower plasma aldosterone and higher renin and consequently lower ARR in both the PA and EH groups. At a cutoff of .7(ng/dL)/(μIU/mL), ARR before washout had 96.3% sensitivity, 61.2% specificity, .33 PPV, and .99 NPV. At a lower cutoff of .5(ng/dL)/(μIU/mL), the sensitivity, specificity, PPV, and NPV were 97.7%, 52.0%, .29, and .99, respectively. CONCLUSION: ARR prior to washout of antihypertensives is a sensitive screening test for PA. Washout of antihypertensives could be omitted and further investigation for PA is not warranted if ARR is ≤ .7(ng/dL)/(μIU/mL) before washout.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Liu X, Hao S, Bian J, et al. Performance of Aldosterone-to-renin Ratio Before Washout of Antihypertensive Drugs in Screening of Primary Aldosteronism. J Clin Endocrinol Metab. 2024. PMID: 38381080. doi:10.1210/clinem/dgae094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。